-
1
-
-
84957852098
-
Les acides nucléiques du plasma sanguin chez l'homme
-
(in French)
-
Mandel, P. & Métais, P. Les acides nucléiques du plasma sanguin chez l'homme. C. R. Seances Soc. Biol. Fil. 142, 241-243 (in French) (1948).
-
(1948)
C. R. Seances Soc. Biol. Fil.
, vol.142
, pp. 241-243
-
-
Mandel, P.1
Métais, P.2
-
2
-
-
84978036286
-
Origins, structures, and functions of circulating DNA in oncology
-
Thierry, A. R., El Messaoudi, S., Gahan, P. B., Anker, P. & Stroun, M. Origins, structures, and functions of circulating DNA in oncology. Cancer Metastasis Rev. 35, 347-376 (2016).
-
(2016)
Cancer Metastasis Rev.
, vol.35
, pp. 347-376
-
-
Thierry, A.R.1
El Messaoudi, S.2
Gahan, P.B.3
Anker, P.4
Stroun, M.5
-
3
-
-
84903549166
-
Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer
-
Mouliere, F., El Messaoudi, S., Pang, D., Dritschilo, A. & Thierry, A. R. Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer. Mol. Oncol. 8, 927-941 (2014).
-
(2014)
Mol. Oncol.
, vol.8
, pp. 927-941
-
-
Mouliere, F.1
El Messaoudi, S.2
Pang, D.3
Dritschilo, A.4
Thierry, A.R.5
-
4
-
-
80052436485
-
High fragmentation characterizes tumour-derived circulating DNA
-
Mouliere, F. et al. High fragmentation characterizes tumour-derived circulating DNA. PLoS ONE 6, e23418 (2011).
-
(2011)
PLoS ONE
, vol.6
, pp. e23418
-
-
Mouliere, F.1
-
5
-
-
0017360626
-
Free DNA in the serum of cancer patients and the effect of therapy
-
Leon, S. A., Shapiro, B., Sklaroff, D. M. & Yaros, M. J. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 37, 646-650 (1977).
-
(1977)
Cancer Res.
, vol.37
, pp. 646-650
-
-
Leon, S.A.1
Shapiro, B.2
Sklaroff, D.M.3
Yaros, M.J.4
-
6
-
-
84907236810
-
Elevated cell-free plasma DNA level as an independent predictor of mortality in patients with severe traumatic brain injury
-
Rodrigues Filho, E. M. et al. Elevated cell-free plasma DNA level as an independent predictor of mortality in patients with severe traumatic brain injury. J. Neurotrauma 31, 1639-1646 (2014).
-
(2014)
J. Neurotrauma
, vol.31
, pp. 1639-1646
-
-
Rodrigues Filho, E.M.1
-
7
-
-
78650868368
-
The value of serial plasma nuclear and mitochondrial DNA levels in patients with acute ischemic stroke
-
Tsai, N.-W. et al. The value of serial plasma nuclear and mitochondrial DNA levels in patients with acute ischemic stroke. Clin. Chim. Acta 412, 476-479 (2011).
-
(2011)
Clin. Chim. Acta
, vol.412
, pp. 476-479
-
-
Tsai, N.-W.1
-
8
-
-
84904816748
-
Direct measurement of cell-free DNA from serially collected capillary plasma during incremental exercise
-
Breitbach, S., Sterzing, B., Magallanes, C., Tug, S. & Simon, P. Direct measurement of cell-free DNA from serially collected capillary plasma during incremental exercise. J. Appl. Physiol. 117, 119-130 (2014).
-
(2014)
J. Appl. Physiol.
, vol.117
, pp. 119-130
-
-
Breitbach, S.1
Sterzing, B.2
Magallanes, C.3
Tug, S.4
Simon, P.5
-
9
-
-
84903776814
-
Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection
-
De Vlaminck, I. et al. Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. Sci. Transl Med. 6, 241ra77 (2014).
-
(2014)
Sci. Transl Med.
, vol.6
, pp. 241ra77
-
-
De Vlaminck, I.1
-
10
-
-
84945577400
-
Noninvasive monitoring of infection and rejection after lung transplantation
-
De Vlaminck, I. et al. Noninvasive monitoring of infection and rejection after lung transplantation. Proc. Natl Acad. Sci. USA 112, 13336-13341 (2015).
-
(2015)
Proc. Natl Acad. Sci. USA
, vol.112
, pp. 13336-13341
-
-
De Vlaminck, I.1
-
11
-
-
0342618532
-
Presence of fetal DNA in maternal plasma and serum
-
Lo, Y. M. D. et al. Presence of fetal DNA in maternal plasma and serum. Lancet 350, 485-487 (1997).
-
(1997)
Lancet
, vol.350
, pp. 485-487
-
-
Lo, Y.M.D.1
-
12
-
-
29544450593
-
Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy
-
Hyett, J. A. et al. Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy. Prenat. Diagn. 25, 1111-1116 (2005).
-
(2005)
Prenat. Diagn.
, vol.25
, pp. 1111-1116
-
-
Hyett, J.A.1
-
13
-
-
0034734711
-
Prenatal DNA diagnosis of a single-gene disorder from maternal plasma
-
Saito, H., Sekizawa, A., Morimoto, T., Suzuki, M. & Yanaihara, T. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 356, 1170 (2000).
-
(2000)
Lancet
, vol.356
, pp. 1170
-
-
Saito, H.1
Sekizawa, A.2
Morimoto, T.3
Suzuki, M.4
Yanaihara, T.5
-
14
-
-
34548727890
-
Digital PCR for the molecular detection of fetal chromosomal aneuploidy
-
Lo, Y. M. D. et al. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc. Natl Acad. Sci. USA 104, 13116-13121 (2007).
-
(2007)
Proc. Natl Acad. Sci. USA
, vol.104
, pp. 13116-13121
-
-
Lo, Y.M.D.1
-
15
-
-
84921815149
-
Non-invasive prenatal testing: A review of international implementation and challenges
-
Allyse, M. et al. Non-invasive prenatal testing: a review of international implementation and challenges. Int. J. Womens Health 7, 113-126 (2015).
-
(2015)
Int. J. Womens Health
, vol.7
, pp. 113-126
-
-
Allyse, M.1
-
16
-
-
84904273806
-
Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: A reliable accurate prenatal non-invasive diagnosis (RAPID) protocol
-
Hill, M. et al. Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol. BMC Pregnancy Childbirth 14, 229 (2014).
-
(2014)
BMC Pregnancy Childbirth
, vol.14
, pp. 229
-
-
Hill, M.1
-
17
-
-
0024420298
-
Neoplastic characteristics of the DNA found in the plasma of cancer patients
-
Stroun, M. et al. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 46, 318-322 (1989).
-
(1989)
Oncology
, vol.46
, pp. 318-322
-
-
Stroun, M.1
-
18
-
-
0025782858
-
Identification of p53 gene mutations in bladder cancers and urine samples
-
Sidransky, D. et al. Identification of p53 gene mutations in bladder cancers and urine samples. Science 252, 706-709 (1991).
-
(1991)
Science
, vol.252
, pp. 706-709
-
-
Sidransky, D.1
-
19
-
-
0026537986
-
Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors
-
Sidransky, D. et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256, 102-105 (1992).
-
(1992)
Science
, vol.256
, pp. 102-105
-
-
Sidransky, D.1
-
20
-
-
0028342395
-
Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia
-
Caldas, C. et al. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res. 54, 3568-3573 (1994).
-
(1994)
Cancer Res.
, vol.54
, pp. 3568-3573
-
-
Caldas, C.1
-
21
-
-
0028210781
-
Detection of oncogene mutations in sputum precedes diagnosis of lung cancer
-
Mao, L., Hruban, R. H., Boyle, J. O., Tockman, M. & Sidransky, D. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res. 54, 1634-1637 (1994).
-
(1994)
Cancer Res.
, vol.54
, pp. 1634-1637
-
-
Mao, L.1
Hruban, R.H.2
Boyle, J.O.3
Tockman, M.4
Sidransky, D.5
-
22
-
-
0027299334
-
Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA)
-
Takeda, S., Ichii, S. & Nakamura, Y. Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA). Hum. Mutat. 2, 112-117 (1993).
-
(1993)
Hum. Mutat.
, vol.2
, pp. 112-117
-
-
Takeda, S.1
Ichii, S.2
Nakamura, Y.3
-
23
-
-
0028225017
-
Soluble normal and mutated DNA-sequences from single-copy genes in human blood
-
Sorenson, G. D. et al. Soluble normal and mutated DNA-sequences from single-copy genes in human blood. Cancer Epidemiol. Biomarkers Prev. 3, 67-71 (1994).
-
(1994)
Cancer Epidemiol. Biomarkers Prev.
, vol.3
, pp. 67-71
-
-
Sorenson, G.D.1
-
24
-
-
24344497920
-
Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer
-
Swisher, E. M. et al. Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer. Am. J. Obstet. Gynecol. 193, 662-667 (2005).
-
(2005)
Am. J. Obstet. Gynecol.
, vol.193
, pp. 662-667
-
-
Swisher, E.M.1
-
25
-
-
33746100318
-
Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer
-
Kimura, H. et al. Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer. Clin. Cancer Res. 12, 3915-3921 (2006).
-
(2006)
Clin. Cancer Res.
, vol.12
, pp. 3915-3921
-
-
Kimura, H.1
-
26
-
-
0032696782
-
Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: A prospect for early diagnosis
-
Sozzi, G., Musso, K., Ratcliffe, C., Goldstraw, P. & Pierotti, M. A. Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis. Clin. Cancer Res. 5, 2689-2692 (1999).
-
(1999)
Clin. Cancer Res.
, vol.5
, pp. 2689-2692
-
-
Sozzi, G.1
Musso, K.2
Ratcliffe, C.3
Goldstraw, P.4
Pierotti, M.A.5
-
27
-
-
0037055554
-
Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis
-
Lecomte, T. et al. Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis. Int. J. Cancer 100, 542-548 (2002).
-
(2002)
Int. J. Cancer
, vol.100
, pp. 542-548
-
-
Lecomte, T.1
-
29
-
-
0042307371
-
Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations
-
Dressman, D., Yan, H., Traverso, G., Kinzler, K. W. & Vogelstein, B. Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations. Proc. Natl Acad. Sci. USA 100, 8817-8822 (2003).
-
(2003)
Proc. Natl Acad. Sci. USA
, vol.100
, pp. 8817-8822
-
-
Dressman, D.1
Yan, H.2
Traverso, G.3
Kinzler, K.W.4
Vogelstein, B.5
-
30
-
-
28044468634
-
Detection and quantification of mutations in the plasma of patients with colorectal tumors
-
Diehl, F. et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc. Natl Acad. Sci. USA 102, 16368-16373 (2005).
-
(2005)
Proc. Natl Acad. Sci. USA
, vol.102
, pp. 16368-16373
-
-
Diehl, F.1
-
31
-
-
51349141191
-
Circulating mutant DNA to assess tumor dynamics
-
Diehl, F. et al. Circulating mutant DNA to assess tumor dynamics. Nat. Med. 14, 985-990 (2008).
-
(2008)
Nat. Med.
, vol.14
, pp. 985-990
-
-
Diehl, F.1
-
32
-
-
65249127504
-
Noninvasive detection of EGFR T790M in gefitinib or erlotinib resistant non-small cell lung cancer
-
Kuang, Y. et al. Noninvasive detection of EGFR T790M in gefitinib or erlotinib resistant non-small cell lung cancer. Clin. Cancer Res. 15, 2630-2636 (2009).
-
(2009)
Clin. Cancer Res.
, vol.15
, pp. 2630-2636
-
-
Kuang, Y.1
-
33
-
-
84969903042
-
Circulating cell-free DNA has a high degree of specificity to detect exon 19 deletions and the single-point substitution mutation L858R in non-small cell lung cancer
-
Qian, X. et al. Circulating cell-free DNA has a high degree of specificity to detect exon 19 deletions and the single-point substitution mutation L858R in non-small cell lung cancer. Oncotarget 7, 29154-29165 (2016).
-
(2016)
Oncotarget
, vol.7
, pp. 29154-29165
-
-
Qian, X.1
-
34
-
-
84861746437
-
Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA
-
Forshew, T. et al. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci. Transl Med. 4, 136ra68 (2012).
-
(2012)
Sci. Transl Med.
, vol.4
, pp. 136ra68
-
-
Forshew, T.1
-
35
-
-
84875520648
-
Analysis of circulating tumor DNA to monitor metastatic breast cancer
-
Dawson, S.-J. et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N. Engl. J. Med. 368, 1199-1209 (2013).
-
(2013)
N. Engl. J. Med.
, vol.368
, pp. 1199-1209
-
-
Dawson, S.-J.1
-
36
-
-
84870312106
-
Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing
-
Leary, R. J. et al. Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing. Sci. Transl Med. 4, 162ra154 (2012).
-
(2012)
Sci. Transl Med.
, vol.4
, pp. 162ra154
-
-
Leary, R.J.1
-
37
-
-
84872020299
-
Cancer genome scanning in plasma: Detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing
-
Chan, K. C. A. et al. Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing. Clin. Chem. 59, 211-224 (2013).
-
(2013)
Clin. Chem.
, vol.59
, pp. 211-224
-
-
Chan, K.C.A.1
-
38
-
-
84875824898
-
Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing
-
Heitzer, E. et al. Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing. Genome Med. 5, 30 (2013).
-
(2013)
Genome Med.
, vol.5
, pp. 30
-
-
Heitzer, E.1
-
39
-
-
84877579861
-
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
-
Murtaza, M. et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 497, 108-112 (2013).
-
(2013)
Nature
, vol.497
, pp. 108-112
-
-
Murtaza, M.1
-
40
-
-
84871756952
-
Use of research biopsies in clinical trials: Are risks and benefits adequately discussed?
-
Overman, M. J. et al. Use of research biopsies in clinical trials: are risks and benefits adequately discussed? J. Clin. Oncol. 31, 17-22 (2013).
-
(2013)
J. Clin. Oncol.
, vol.31
, pp. 17-22
-
-
Overman, M.J.1
-
41
-
-
84896719958
-
Success and failure rates of tumor genotyping techniques in routine pathological samples with non-small-cell lung cancer
-
VanderLaan, P. A. et al. Success and failure rates of tumor genotyping techniques in routine pathological samples with non-small-cell lung cancer. Lung Cancer 84, 39-44 (2014).
-
(2014)
Lung Cancer
, vol.84
, pp. 39-44
-
-
VanderLaan, P.A.1
-
42
-
-
84908614640
-
Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): A double-blind, randomised, phase 3 trial
-
Ellis, P. M. et al. Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial. Lancet Oncol. 15, 1379-1388 (2014).
-
(2014)
Lancet Oncol.
, vol.15
, pp. 1379-1388
-
-
Ellis, P.M.1
-
43
-
-
84984619721
-
Commentary on tumor heterogeneity
-
Popper, H. H. Commentary on tumor heterogeneity. Transl Lung Cancer Res. 5, 433-435 (2016).
-
(2016)
Transl Lung Cancer Res.
, vol.5
, pp. 433-435
-
-
Popper, H.H.1
-
44
-
-
84906890825
-
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: A proof-of-principle
-
De Mattos-Arruda, L. et al. Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle. Ann. Oncol. 25, 1729-1735 (2014).
-
(2014)
Ann. Oncol.
, vol.25
, pp. 1729-1735
-
-
De Mattos-Arruda, L.1
-
45
-
-
84926416450
-
Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types
-
Lebofsky, R. et al. Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types. Mol. Oncol. 9, 783-790 (2015).
-
(2015)
Mol. Oncol.
, vol.9
, pp. 783-790
-
-
Lebofsky, R.1
-
46
-
-
84964767208
-
Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer
-
Jamal-Hanjani, M. et al. Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer. Ann. Oncol. 27, 862-867 (2016).
-
(2016)
Ann. Oncol.
, vol.27
, pp. 862-867
-
-
Jamal-Hanjani, M.1
-
47
-
-
84946559772
-
Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer
-
Murtaza, M. et al. Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer. Nat. Commun. 6, 8760 (2015).
-
(2015)
Nat. Commun.
, vol.6
, pp. 8760
-
-
Murtaza, M.1
-
48
-
-
33644544070
-
Serum tumor markers in breast cancer: Are they of clinical value?
-
Duffy, M. J. Serum tumor markers in breast cancer: are they of clinical value? Clin. Chem. 52, 345-351 (2006).
-
(2006)
Clin. Chem.
, vol.52
, pp. 345-351
-
-
Duffy, M.J.1
-
49
-
-
69349096036
-
Exposure to low-dose ionizing radiation from medical imaging procedures
-
Fazel, R. et al. Exposure to low-dose ionizing radiation from medical imaging procedures. N. Engl. J. Med. 361, 849-857 (2009).
-
(2009)
N. Engl. J. Med.
, vol.361
, pp. 849-857
-
-
Fazel, R.1
-
50
-
-
84901842265
-
Double-stranded DNA in exosomes: A novel biomarker in cancer detection
-
Thakur, B. K. et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res. 24, 766-769 (2014).
-
(2014)
Cell Res.
, vol.24
, pp. 766-769
-
-
Thakur, B.K.1
-
51
-
-
84894189683
-
Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer
-
Kahlert, C. et al. Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J. Biol. Chem. 289, 3869-3875 (2014).
-
(2014)
J. Biol. Chem.
, vol.289
, pp. 3869-3875
-
-
Kahlert, C.1
-
52
-
-
0035866393
-
DNA fragments in the blood plasma of cancer patients: Quantitations and evidence for their origin from apoptotic and necrotic cells
-
Jahr, S. et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 61, 1659-1665 (2001).
-
(2001)
Cancer Res.
, vol.61
, pp. 1659-1665
-
-
Jahr, S.1
-
53
-
-
0034750559
-
About the possible origin and mechanism of circulating DNA: Apoptosis and active DNA release
-
Stroun, M., Lyautey, J., Lederrey, C., Olson-Sand, A. & Anker, P. About the possible origin and mechanism of circulating DNA: apoptosis and active DNA release. Clin. Chim. Acta 313, 139-142 (2001).
-
(2001)
Clin. Chim. Acta
, vol.313
, pp. 139-142
-
-
Stroun, M.1
Lyautey, J.2
Lederrey, C.3
Olson-Sand, A.4
Anker, P.5
-
54
-
-
0033870263
-
Genetic analysis of DNA excreted in urine: A new approach for detecting specific genomic DNA sequences from cells dying in an organism
-
Botezatu, I. et al. Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism. Clin. Chem. 46, 1078-1084 (2000).
-
(2000)
Clin. Chem.
, vol.46
, pp. 1078-1084
-
-
Botezatu, I.1
-
55
-
-
51049091006
-
Quantitative analysis of the transrenal excretion of circulating EBV DNA in nasopharyngeal carcinoma patients
-
Chan, K. C. A., Leung, S. F., Yeung, S. W., Chan, A. T. C. & Lo, Y. M. D. Quantitative analysis of the transrenal excretion of circulating EBV DNA in nasopharyngeal carcinoma patients. Clin. Cancer Res. 14, 4809 (2008).
-
(2008)
Clin. Cancer Res.
, vol.14
, pp. 4809
-
-
Chan, K.C.A.1
Leung, S.F.2
Yeung, S.W.3
Chan, A.T.C.4
Lo, Y.M.D.5
-
56
-
-
84955259942
-
Genomic alterations in liquid biopsies from patients with bladder cancer
-
Birkenkamp-Demtröder, K. et al. Genomic alterations in liquid biopsies from patients with bladder cancer. Eur. Urol. 70, 75-82 (2016).
-
(2016)
Eur. Urol.
, vol.70
, pp. 75-82
-
-
Birkenkamp-Demtröder, K.1
-
57
-
-
2342642789
-
Human urine contains small, 150 to 250 nucleotide-sized, soluble DNA derived from the circulation and may be useful in the detection of colorectal cancer
-
Su, Y.-H. et al. Human urine contains small, 150 to 250 nucleotide-sized, soluble DNA derived from the circulation and may be useful in the detection of colorectal cancer. J. Mol. Diagn. 6, 101-107 (2004).
-
(2004)
J. Mol. Diagn.
, vol.6
, pp. 101-107
-
-
Su, Y.-H.1
-
58
-
-
84991067919
-
A highly sensitive and quantitative test platform for detection of NSCLC EGFR mutations in urine and plasma
-
Reckamp, K. L. et al. A highly sensitive and quantitative test platform for detection of NSCLC EGFR mutations in urine and plasma. J. Thorac. Oncol. 11, 1690-1700 (2016).
-
(2016)
J. Thorac. Oncol.
, vol.11
, pp. 1690-1700
-
-
Reckamp, K.L.1
-
59
-
-
84938632046
-
Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord
-
Wang, Y. et al. Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord. Proc. Natl Acad. Sci. USA 112, 9704-9709 (2015).
-
(2015)
Proc. Natl Acad. Sci. USA
, vol.112
, pp. 9704-9709
-
-
Wang, Y.1
-
60
-
-
84923869755
-
Brain tumor mutations detected in cerebral spinal fluid
-
Pan, W., Gu, W., Nagpal, S., Gephart, M. H. & Quake, S. R. Brain tumor mutations detected in cerebral spinal fluid. Clin. Chem. 61, 514-522 (2015).
-
(2015)
Clin. Chem.
, vol.61
, pp. 514-522
-
-
Pan, W.1
Gu, W.2
Nagpal, S.3
Gephart, M.H.4
Quake, S.R.5
-
61
-
-
84946719441
-
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma
-
De Mattos-Arruda, L. et al. Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma. Nat. Commun. 6, 8839 (2015).
-
(2015)
Nat. Commun.
, vol.6
, pp. 8839
-
-
De Mattos-Arruda, L.1
-
62
-
-
0028941014
-
PCR-detection of tumor-derived p53 DNA in cerebrospinal fluid
-
Rhodes, C. H., Honsinger, C. & Sorenson, G. D. PCR-detection of tumor-derived p53 DNA in cerebrospinal fluid. Am. J. Clin. Pathol. 103, 404-408 (1995).
-
(1995)
Am. J. Clin. Pathol.
, vol.103
, pp. 404-408
-
-
Rhodes, C.H.1
Honsinger, C.2
Sorenson, G.D.3
-
63
-
-
84866558696
-
Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas
-
Sriram, K. B. et al. Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas. BMC Cancer 12, 428 (2012).
-
(2012)
BMC Cancer
, vol.12
, pp. 428
-
-
Sriram, K.B.1
-
64
-
-
37549069900
-
Mitochondrial resequencing arrays detect tumor-specific mutations in salivary rinses of patients with head and neck cancer
-
Mithani, S. K. et al. Mitochondrial resequencing arrays detect tumor-specific mutations in salivary rinses of patients with head and neck cancer. Clin. Cancer Res. 13, 7335-7340 (2007).
-
(2007)
Clin. Cancer Res.
, vol.13
, pp. 7335-7340
-
-
Mithani, S.K.1
-
65
-
-
84954306330
-
Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin
-
Snyder, M. W., Kircher, M., Hill, A. J., Daza, R. M. & Shendure, J. Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin. Cell 164, 57-68 (2016).
-
(2016)
Cell
, vol.164
, pp. 57-68
-
-
Snyder, M.W.1
Kircher, M.2
Hill, A.J.3
Daza, R.M.4
Shendure, J.5
-
66
-
-
84962407100
-
Identification of tissue-specific cell death using methylation patterns of circulating DNA
-
Lehmann-Werman, R. et al. Identification of tissue-specific cell death using methylation patterns of circulating DNA. Proc. Natl Acad. Sci. USA 113, E1826-E1834 (2016).
-
(2016)
Proc. Natl Acad. Sci. USA
, vol.113
, pp. E1826-E1834
-
-
Lehmann-Werman, R.1
-
67
-
-
84943375035
-
Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments
-
Sun, K. et al. Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments. Proc. Natl Acad. Sci. USA 112, E5503-E5512 (2015).
-
(2015)
Proc. Natl Acad. Sci. USA
, vol.112
, pp. E5503-E5512
-
-
Sun, K.1
-
68
-
-
0036177799
-
Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation
-
Lui, Y. Y. N. et al. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin. Chem. 48, 421-427 (2002).
-
(2002)
Clin. Chem.
, vol.48
, pp. 421-427
-
-
Lui, Y.Y.N.1
-
69
-
-
84928697985
-
Exercise-induced increases in cell free DNA in human plasma originate predominantly from cells of the haematopoietic lineage
-
Tug, S. et al. Exercise-induced increases in cell free DNA in human plasma originate predominantly from cells of the haematopoietic lineage. Exerc. Immunol. Rev. 21, 164-173 (2015).
-
(2015)
Exerc. Immunol. Rev.
, vol.21
, pp. 164-173
-
-
Tug, S.1
-
70
-
-
0042334866
-
Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma
-
To, E. W. H. et al. Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma. Clin. Cancer Res. 9, 3254-3259 (2003).
-
(2003)
Clin. Cancer Res.
, vol.9
, pp. 3254-3259
-
-
To, E.W.H.1
-
71
-
-
0033364339
-
Rapid clearance of fetal DNA from maternal plasma
-
Lo, Y. M. et al. Rapid clearance of fetal DNA from maternal plasma. Am. J. Hum. Genet. 64, 218-224 (1999).
-
(1999)
Am. J. Hum. Genet.
, vol.64
, pp. 218-224
-
-
Lo, Y.M.1
-
72
-
-
84989842529
-
Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: A qualitative study
-
Wang, Y., Chen, M., Xiao, N. & Liu, H. Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: a qualitative study. Gene 590, 142-148 (2016).
-
(2016)
Gene
, vol.590
, pp. 142-148
-
-
Wang, Y.1
Chen, M.2
Xiao, N.3
Liu, H.4
-
73
-
-
33646850536
-
Circulating DNA and DNase activity in human blood
-
Tamkovich, S. N. et al. Circulating DNA and DNase activity in human blood. Ann. NY Acad. Sci. 1075, 191-196 (2006).
-
(2006)
Ann. NY Acad. Sci.
, vol.1075
, pp. 191-196
-
-
Tamkovich, S.N.1
-
74
-
-
84868272966
-
High resolution size analysis of fetal DNA in the urine of pregnant women by paired-end massively parallel sequencing
-
Tsui, N. B. Y. et al. High resolution size analysis of fetal DNA in the urine of pregnant women by paired-end massively parallel sequencing. PLoS ONE 7, e48319 (2012).
-
(2012)
PLoS ONE
, vol.7
, pp. e48319
-
-
Tsui, N.B.Y.1
-
75
-
-
0015450598
-
The clearance and localization of nucleic acids by New Zealand and normal mice
-
Chused, T. M., Steinberg, A. D. & Talal, N. The clearance and localization of nucleic acids by New Zealand and normal mice. Clin. Exp. Immunol. 12, 465-476 (1972).
-
(1972)
Clin. Exp. Immunol.
, vol.12
, pp. 465-476
-
-
Chused, T.M.1
Steinberg, A.D.2
Talal, N.3
-
76
-
-
0031815875
-
Cell-free DNA in human blood plasma: Length measurements in patients with pancreatic cancer and healthy controls
-
Giacona, M. B. et al. Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. Pancreas 17, 89-97 (1998).
-
(1998)
Pancreas
, vol.17
, pp. 89-97
-
-
Giacona, M.B.1
-
77
-
-
78650207098
-
Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus
-
Lo, Y. M. D. et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci. Transl Med. 2, 61ra91 (2010).
-
(2010)
Sci. Transl Med.
, vol.2
, pp. 61ra91
-
-
Lo, Y.M.D.1
-
78
-
-
78049435890
-
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts
-
Thierry, A. R. et al. Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts. Nucleic Acids Res. 38, 6159-6175 (2010).
-
(2010)
Nucleic Acids Res.
, vol.38
, pp. 6159-6175
-
-
Thierry, A.R.1
-
79
-
-
0027414010
-
Measurement of deoxyribonuclease i activity in human tissues and body fluids by a single radial enzyme-diffusion method
-
Nadano, D., Yasuda, T. & Kishi, K. Measurement of deoxyribonuclease I activity in human tissues and body fluids by a single radial enzyme-diffusion method. Clin. Chem. 39, 448-452 (1993).
-
(1993)
Clin. Chem.
, vol.39
, pp. 448-452
-
-
Nadano, D.1
Yasuda, T.2
Kishi, K.3
-
80
-
-
84878734930
-
Circulating cell-free DNA from colorectal cancer patients may reveal high KRAS or BRAF mutation load
-
Mouliere, F. et al. Circulating cell-free DNA from colorectal cancer patients may reveal high KRAS or BRAF mutation load. Transl Oncol. 6, 319-328 (2013).
-
(2013)
Transl Oncol.
, vol.6
, pp. 319-328
-
-
Mouliere, F.1
-
81
-
-
84982840399
-
Fragment length of circulating tumor DNA
-
Underhill, H. R. et al. Fragment length of circulating tumor DNA. PLoS Genet. 12, 426-437 (2016).
-
(2016)
PLoS Genet.
, vol.12
, pp. 426-437
-
-
Underhill, H.R.1
-
82
-
-
84865803081
-
Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA
-
Gorges, T. M. et al. Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA. Biomarkers 17, 498-506 (2012).
-
(2012)
Biomarkers
, vol.17
, pp. 498-506
-
-
Gorges, T.M.1
-
83
-
-
84863230684
-
Nonhematopoietically derived DNA is shorter than hematopoietically derived DNA in plasma: A transplantation model
-
Zheng, Y. W. L. et al. Nonhematopoietically derived DNA is shorter than hematopoietically derived DNA in plasma: a transplantation model. Clin. Chem. 58, 549-558 (2012).
-
(2012)
Clin. Chem.
, vol.58
, pp. 549-558
-
-
Zheng, Y.W.L.1
-
84
-
-
84964671215
-
The long and short of circulating cell-free DNA and the ins and outs of molecular diagnostics
-
Jiang, P. & Lo, Y. M. D. The long and short of circulating cell-free DNA and the ins and outs of molecular diagnostics. Trends Genet. 32, 360-371 (2016).
-
(2016)
Trends Genet.
, vol.32
, pp. 360-371
-
-
Jiang, P.1
Lo, Y.M.D.2
-
85
-
-
84942927070
-
Noninvasive prenatal testing by nanopore sequencing of maternal plasma DNA: Feasibility assessment
-
Cheng, S. H. et al. Noninvasive prenatal testing by nanopore sequencing of maternal plasma DNA: feasibility assessment. Clin. Chem. 61, 1305-1306 (2015).
-
(2015)
Clin. Chem.
, vol.61
, pp. 1305-1306
-
-
Cheng, S.H.1
-
86
-
-
84897076233
-
Direct quantification of cell-free, circulating DNA from unpurified plasma
-
Breitbach, S. et al. Direct quantification of cell-free, circulating DNA from unpurified plasma. PLoS ONE 9, e87838 (2014).
-
(2014)
PLoS ONE
, vol.9
, pp. e87838
-
-
Breitbach, S.1
-
87
-
-
85016263796
-
Carrier molecules and extraction of circulating tumor DNA for next generation sequencing in colorectal cancer
-
Beránek, M. et al. Carrier molecules and extraction of circulating tumor DNA for next generation sequencing in colorectal cancer. Acta Medica (Hradec Kralove) 59, 54-58 (2016).
-
(2016)
Acta Medica (Hradec Kralove)
, vol.59
, pp. 54-58
-
-
Beránek, M.1
-
88
-
-
84875500588
-
Single-stranded DNA library preparation for the sequencing of ancient or damaged DNA
-
Gansauge, M.-T. & Meyer, M. Single-stranded DNA library preparation for the sequencing of ancient or damaged DNA. Nat. Protoc. 8, 737-748 (2013).
-
(2013)
Nat. Protoc.
, vol.8
, pp. 737-748
-
-
Gansauge, M.-T.1
Meyer, M.2
-
89
-
-
84974830961
-
Single-stranded DNA library preparation uncovers the origin and diversity of ultrashort cell-free DNA in plasma
-
Burnham, P. et al. Single-stranded DNA library preparation uncovers the origin and diversity of ultrashort cell-free DNA in plasma. Sci. Rep. 6, 27859 (2016).
-
(2016)
Sci. Rep.
, vol.6
, pp. 27859
-
-
Burnham, P.1
-
90
-
-
84857941940
-
Fragments of cell-free DNA increase transcription in human mesenchymal stem cells, activate TLR-dependent signal pathway, and suppress apoptosis
-
Kostyuk, S. V. et al. Fragments of cell-free DNA increase transcription in human mesenchymal stem cells, activate TLR-dependent signal pathway, and suppress apoptosis. Biochem. (Mosc.) Suppl. Ser. B Biomed. Chem. 6, 68-74 (2012).
-
(2012)
Biochem. (Mosc.) Suppl. Ser. B Biomed. Chem.
, vol.6
, pp. 68-74
-
-
Kostyuk, S.V.1
-
91
-
-
84986905526
-
Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance
-
Nishimoto, S. et al. Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance. Sci. Adv. 2, e1501332 (2016).
-
(2016)
Sci. Adv.
, vol.2
, pp. e1501332
-
-
Nishimoto, S.1
-
92
-
-
84887085890
-
DNA released by leukemic cells contributes to the disruption of the bone marrow microenvironment
-
Dvoráková, M. et al. DNA released by leukemic cells contributes to the disruption of the bone marrow microenvironment. Oncogene 32, 5201-5209 (2013).
-
(2013)
Oncogene
, vol.32
, pp. 5201-5209
-
-
Dvoráková, M.1
-
93
-
-
4444270042
-
Cellular uptake of deoxyribonucleic acid by human tissue culture cells
-
Gartler, S. M. Cellular uptake of deoxyribonucleic acid by human tissue culture cells. Nature 184, 1505-1506 (1959).
-
(1959)
Nature
, vol.184
, pp. 1505-1506
-
-
Gartler, S.M.1
-
94
-
-
76549132066
-
Cell-free nucleic acids circulating in the plasma of colorectal cancer patients induce the oncogenic transformation of susceptible cultured cells
-
García-Olmo, D. C. et al. Cell-free nucleic acids circulating in the plasma of colorectal cancer patients induce the oncogenic transformation of susceptible cultured cells. Cancer Res. 70, 560-567 (2010).
-
(2010)
Cancer Res.
, vol.70
, pp. 560-567
-
-
García-Olmo, D.C.1
-
95
-
-
84931830812
-
Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells
-
Ju, Y. S. et al. Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells. Genome Res. 25, 814-824 (2015).
-
(2015)
Genome Res.
, vol.25
, pp. 814-824
-
-
Ju, Y.S.1
-
96
-
-
0002713231
-
Allele-specific enzymatic amplification of beta-globin genomic DNA for diagnosis of sickle cell anemia
-
Wu, D. Y., Ugozzoli, L, Pal, B. K. & Wallace, R. B. Allele-specific enzymatic amplification of beta-globin genomic DNA for diagnosis of sickle cell anemia. Proc. Natl Acad. Sci. USA 86, 2757-2760 (1989).
-
(1989)
Proc. Natl Acad. Sci. USA
, vol.86
, pp. 2757-2760
-
-
Wu, D.Y.1
Ugozzoli, L.2
Pal, B.K.3
Wallace, R.B.4
-
97
-
-
0024605518
-
Analysis of any point mutation in DNA. the amplification refractory mutation system (ARMS)
-
Newton, C. R. et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res. 17, 2503-2516 (1989).
-
(1989)
Nucleic Acids Res.
, vol.17
, pp. 2503-2516
-
-
Newton, C.R.1
-
98
-
-
85016325776
-
-
QIAGEN. Therascreen EGFR Plasma RGQ PCR Kit Handbook-Version 2
-
QIAGEN. Therascreen EGFR Plasma RGQ PCR Kit Handbook-Version 2. https://www.qiagen.com/gb/resources/resourcedetail?id=eb32e329-3422-4eda-b3d6-e44ed787002a&lang=en (2014).
-
(2014)
-
-
-
99
-
-
85016317311
-
-
US Food & Drug Administration. Premarket approval P150044-Cobas EGFR MUTATION TEST V2. FDA
-
US Food & Drug Administration. Premarket approval P150044-Cobas EGFR MUTATION TEST V2. FDA http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P150044 (2016).
-
(2016)
-
-
-
100
-
-
84947967799
-
Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer
-
Schiavon, G. et al. Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer. Sci. Transl Med. 7, 313ra182 (2015).
-
(2015)
Sci. Transl Med.
, vol.7
, pp. 313ra182
-
-
Schiavon, G.1
-
101
-
-
84884176329
-
Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients
-
Taly, V. et al. Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients. Clin. Chem. 59, 1722-1731 (2013).
-
(2013)
Clin. Chem.
, vol.59
, pp. 1722-1731
-
-
Taly, V.1
-
102
-
-
84975461688
-
Prospective validation of rapid plasma genotyping for the detection of EGFR and KRAS mutations in advanced lung cancer
-
Sacher, A. G. et al. Prospective validation of rapid plasma genotyping for the detection of EGFR and KRAS mutations in advanced lung cancer. JAMA Oncol. 2, 1014-1022 (2016).
-
(2016)
JAMA Oncol.
, vol.2
, pp. 1014-1022
-
-
Sacher, A.G.1
-
103
-
-
63449103435
-
Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients
-
Yung, T. K. F. et al. Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients. Clin. Cancer Res. 15, 2076-2084 (2009).
-
(2009)
Clin. Cancer Res.
, vol.15
, pp. 2076-2084
-
-
Yung, T.K.F.1
-
104
-
-
84954046405
-
Ultrasensitive detection of multiplexed somatic mutations using MALDI-TOF mass spectrometry
-
Mosko, M. J. et al. Ultrasensitive detection of multiplexed somatic mutations using MALDI-TOF mass spectrometry. J. Mol. Diagn. 18, 23-31 (2016).
-
(2016)
J. Mol. Diagn.
, vol.18
, pp. 23-31
-
-
Mosko, M.J.1
-
105
-
-
13444254296
-
Novel electrophoresis mechanism based on synchronous alternating drag perturbation
-
Marziali, A., Pel, J., Bizzotto, D. & Whitehead, L. A. Novel electrophoresis mechanism based on synchronous alternating drag perturbation. Electrophoresis 26, 82-90 (2005).
-
(2005)
Electrophoresis
, vol.26
, pp. 82-90
-
-
Marziali, A.1
Pel, J.2
Bizzotto, D.3
Whitehead, L.A.4
-
106
-
-
84857077666
-
Winnowing DNA for rare sequences: Highly specific sequence and methylation based enrichment
-
Thompson, J. D., Shibahara, G., Rajan, S., Pel, J. & Marziali, A. Winnowing DNA for rare sequences: highly specific sequence and methylation based enrichment. PLoS ONE 7, e31597 (2012).
-
(2012)
PLoS ONE
, vol.7
, pp. e31597
-
-
Thompson, J.D.1
Shibahara, G.2
Rajan, S.3
Pel, J.4
Marziali, A.5
-
107
-
-
84994805830
-
Elimination of unaltered DNA in mixed clinical samples via nuclease-assisted minor-allele enrichment
-
Song, C. et al. Elimination of unaltered DNA in mixed clinical samples via nuclease-assisted minor-allele enrichment. Nucleic Acids Res. 44, 1-11 (2016).
-
(2016)
Nucleic Acids Res.
, vol.44
, pp. 1-11
-
-
Song, C.1
-
108
-
-
43249116705
-
Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing
-
Li, J. et al. Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing. Nat. Med. 14, 579-584 (2008).
-
(2008)
Nat. Med.
, vol.14
, pp. 579-584
-
-
Li, J.1
-
109
-
-
84873689810
-
Differential strand separation at critical temperature: A minimally disruptive enrichment method for low-abundance unknown DNA mutations
-
Guha, M., Castellanos-Rizaldos, E., Liu, P., Mamon, H. & Makrigiorgos, G. M. Differential strand separation at critical temperature: a minimally disruptive enrichment method for low-abundance unknown DNA mutations. Nucleic Acids Res. 41, e50 (2013).
-
(2013)
Nucleic Acids Res.
, vol.41
, pp. e50
-
-
Guha, M.1
Castellanos-Rizaldos, E.2
Liu, P.3
Mamon, H.4
Makrigiorgos, G.M.5
-
110
-
-
84903218109
-
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
-
Newman, A. M. et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat. Med. 20, 548-554 (2014).
-
(2014)
Nat. Med.
, vol.20
, pp. 548-554
-
-
Newman, A.M.1
-
111
-
-
84949009842
-
Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA
-
Lanman, R. B. et al. Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA. PLoS ONE 10, e0140712 (2015).
-
(2015)
PLoS ONE
, vol.10
, pp. e0140712
-
-
Lanman, R.B.1
-
112
-
-
84940095522
-
Serial next generation sequencing of circulating cell free DNA evaluating tumour clone response to molecularly targeted drug administration
-
Frenel, J.-S. et al. Serial next generation sequencing of circulating cell free DNA evaluating tumour clone response to molecularly targeted drug administration. Clin. Cancer Res. 21, 4586-4596 (2015).
-
(2015)
Clin. Cancer Res.
, vol.21
, pp. 4586-4596
-
-
Frenel, J.-S.1
-
113
-
-
84863967346
-
Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing
-
Narayan, A. et al. Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing. Cancer Res. 72, 3492-3498 (2012).
-
(2012)
Cancer Res.
, vol.72
, pp. 3492-3498
-
-
Narayan, A.1
-
114
-
-
84966365311
-
Integrated digital error suppression for improved detection of circulating tumor DNA
-
Newman, A. M. et al. Integrated digital error suppression for improved detection of circulating tumor DNA. Nat. Biotechnol. 34, 547-555 (2016).
-
(2016)
Nat. Biotechnol.
, vol.34
, pp. 547-555
-
-
Newman, A.M.1
-
115
-
-
79959353421
-
Detection and quantification of rare mutations with massively parallel sequencing
-
Kinde, I., Wu, J., Papadopoulos, N., Kinzler, K. W. & Vogelstein, B. Detection and quantification of rare mutations with massively parallel sequencing. Proc. Natl Acad. Sci. USA 108, 9530-9535 (2011).
-
(2011)
Proc. Natl Acad. Sci. USA
, vol.108
, pp. 9530-9535
-
-
Kinde, I.1
Wu, J.2
Papadopoulos, N.3
Kinzler, K.W.4
Vogelstein, B.5
-
116
-
-
85016314784
-
-
World Intellectual Property Organization patent WO2016009224A1
-
Rosenfeld, N., Forshew, T., Marass, F. & Murtaza, M. A method for detecting a genetic variant. World Intellectual Property Organization patent WO2016009224A1 (2016).
-
(2016)
A Method for Detecting A Genetic Variant
-
-
Rosenfeld, N.1
Forshew, T.2
Marass, F.3
Murtaza, M.4
-
118
-
-
85016333133
-
Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor DNA assay
-
Schwaederle, M. C. et al. Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor DNA assay. Oncotarget 33, 11004 (2015).
-
(2015)
Oncotarget
, vol.33
, pp. 11004
-
-
Schwaederle, M.C.1
-
119
-
-
84930532904
-
Rapid identification of plasma DNA samples with increased ctDNA levels by a modified FAST-SeqS approach
-
Belic, J. et al. Rapid identification of plasma DNA samples with increased ctDNA levels by a modified FAST-SeqS approach. Clin. Chem. 61, 838-849 (2015).
-
(2015)
Clin. Chem.
, vol.61
, pp. 838-849
-
-
Belic, J.1
-
120
-
-
84945925969
-
Detection of clonal and subclonal copy-number variants in cell-free DNA from patients with breast cancer using a massively multiplexed PCR methodology
-
Kirkizlar, E. et al. Detection of clonal and subclonal copy-number variants in cell-free DNA from patients with breast cancer using a massively multiplexed PCR methodology. Transl Oncol. 8, 407-416 (2015).
-
(2015)
Transl Oncol.
, vol.8
, pp. 407-416
-
-
Kirkizlar, E.1
-
121
-
-
85007602110
-
Exploratory analysis of TP53 mutations in circulating tumour DNA as biomarkers of treatment response for patients with relapsed high-grade serous ovarian carcinoma: A retrospective study
-
Parkinson, C. A. et al. Exploratory analysis of TP53 mutations in circulating tumour DNA as biomarkers of treatment response for patients with relapsed high-grade serous ovarian carcinoma: a retrospective study. PLoS Med. 13, e1002198 (2016).
-
(2016)
PLoS Med.
, vol.13
, pp. e1002198
-
-
Parkinson, C.A.1
-
122
-
-
84898476658
-
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
-
Thierry, A. R. et al. Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA. Nat. Med. 20, 430-435 (2014).
-
(2014)
Nat. Med.
, vol.20
, pp. 430-435
-
-
Thierry, A.R.1
-
123
-
-
33751074674
-
Circulating cell-free DNA: A novel biomarker for response to therapy in ovarian carcinoma
-
Kamat, A. A. et al. Circulating cell-free DNA: a novel biomarker for response to therapy in ovarian carcinoma. Cancer Biol. Ther. 5, 1369-1374 (2006).
-
(2006)
Cancer Biol. Ther.
, vol.5
, pp. 1369-1374
-
-
Kamat, A.A.1
-
124
-
-
84896371874
-
Detection of circulating tumor DNA in early-and late-stage human malignancies
-
Bettegowda, C. et al. Detection of circulating tumor DNA in early-and late-stage human malignancies. Sci. Transl Med. 6, 224ra24 (2014).
-
(2014)
Sci. Transl Med.
, vol.6
, pp. 224ra24
-
-
Bettegowda, C.1
-
125
-
-
84873207633
-
The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer
-
Nygaard, A. D., Garm Spindler, K.-L., Pallisgaard, N., Andersen, R. F. & Jakobsen, A. The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer. Lung Cancer 79, 312-317 (2013).
-
(2013)
Lung Cancer
, vol.79
, pp. 312-317
-
-
Nygaard, A.D.1
Garm Spindler, K.-L.2
Pallisgaard, N.3
Andersen, R.F.4
Jakobsen, A.5
-
126
-
-
76749151984
-
Potential clinical significance of a plasma-based KRAS mutation analysis in patients with advanced non-small cell lung cancer
-
Wang, S. et al. Potential clinical significance of a plasma-based KRAS mutation analysis in patients with advanced non-small cell lung cancer. Clin. Cancer Res. 16, 1324-1330 (2010).
-
(2010)
Clin. Cancer Res.
, vol.16
, pp. 1324-1330
-
-
Wang, S.1
-
127
-
-
34547183500
-
Origin and prognostic value of circulating KRAS mutations in lung cancer patients
-
Gautschi, O. et al. Origin and prognostic value of circulating KRAS mutations in lung cancer patients. Cancer Lett. 254, 265-273 (2007).
-
(2007)
Cancer Lett.
, vol.254
, pp. 265-273
-
-
Gautschi, O.1
-
128
-
-
84958978046
-
Correlation of BRAF mutation status in circulating-free DNA and tumor and association with clinical outcome across four BRAFi and MEKi clinical trials
-
Santiago-Walker, A. et al. Correlation of BRAF mutation status in circulating-free DNA and tumor and association with clinical outcome across four BRAFi and MEKi clinical trials. Clin. Cancer Res. 22, 567-574 (2016).
-
(2016)
Clin. Cancer Res.
, vol.22
, pp. 567-574
-
-
Santiago-Walker, A.1
-
129
-
-
84951757209
-
Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma
-
Gray, E. S. et al. Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma. Oncotarget 6, 42008-42018 (2015).
-
(2015)
Oncotarget
, vol.6
, pp. 42008-42018
-
-
Gray, E.S.1
-
130
-
-
84977068103
-
Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade
-
Lipson, E. J. et al. Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade. J. Immunother. Cancer 2, 42 (2014).
-
(2014)
J. Immunother. Cancer
, vol.2
, pp. 42
-
-
Lipson, E.J.1
-
131
-
-
84925460062
-
PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients
-
Oshiro, C. et al. PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients. Breast Cancer Res. Treat. 150, 299-307 (2015).
-
(2015)
Breast Cancer Res. Treat.
, vol.150
, pp. 299-307
-
-
Oshiro, C.1
-
132
-
-
84996489062
-
Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA
-
364ra155
-
Scherer, F. et al. Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA. Sci. Transl Med. 8, 364ra155 (2016).
-
(2016)
Sci. Transl Med.
, vol.8
-
-
Scherer, F.1
-
133
-
-
85016318635
-
-
Office for National Statistics. Cancer survival by stage at diagnosis for England (experimental statistics): adults diagnosed 2012, 2013 and 2014 and followed up to 2015. ONS
-
Office for National Statistics. Cancer survival by stage at diagnosis for England (experimental statistics): adults diagnosed 2012, 2013 and 2014 and followed up to 2015. ONS https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancersurvival bystageatdiagnosisforenglandexperimental statistics/adultsdiagnosed20122013and2014 andfollowedupto2015 (2016).
-
(2016)
-
-
-
134
-
-
33746155812
-
TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: A prospective study
-
Gormally, E. et al. TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective study. Cancer Res. 66, 6871-6876 (2006).
-
(2006)
Cancer Res.
, vol.66
, pp. 6871-6876
-
-
Gormally, E.1
-
135
-
-
84943394447
-
Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing
-
Amant, F. et al. Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing. JAMA Oncol. 1, 814 (2015).
-
(2015)
JAMA Oncol.
, vol.1
, pp. 814
-
-
Amant, F.1
-
136
-
-
84937459187
-
Noninvasive prenatal testing and incidental detection of occult maternal malignancies
-
Bianchi, D. W. et al. Noninvasive prenatal testing and incidental detection of occult maternal malignancies. JAMA 314, 162 (2015).
-
(2015)
JAMA
, vol.314
, pp. 162
-
-
Bianchi, D.W.1
-
137
-
-
84900992934
-
Detection of cancer DNA in plasma of patients with early-stage breast cancer
-
Beaver, J. A. et al. Detection of cancer DNA in plasma of patients with early-stage breast cancer. Clin. Cancer Res. 20, 2643-2650 (2014).
-
(2014)
Clin. Cancer Res.
, vol.20
, pp. 2643-2650
-
-
Beaver, J.A.1
-
138
-
-
84983534974
-
Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: Implications for cancer screening
-
Cohen, P. A. et al. Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening. BMC Med. 14, 126 (2016).
-
(2016)
BMC Med.
, vol.14
, pp. 126
-
-
Cohen, P.A.1
-
139
-
-
84968779733
-
Enumeration and molecular characterization of tumor cells in lung cancer patients using a novel in vivo device for capturing circulating tumor cells
-
Gorges, T. M. et al. Enumeration and molecular characterization of tumor cells in lung cancer patients using a novel in vivo device for capturing circulating tumor cells. Clin. Cancer Res. 22, 2197-2206 (2016).
-
(2016)
Clin. Cancer Res.
, vol.22
, pp. 2197-2206
-
-
Gorges, T.M.1
-
140
-
-
84872329672
-
Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers
-
167ra4
-
Kinde, I. et al. Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers. Sci. Transl Med. 5, 167ra4 (2013).
-
(2013)
Sci. Transl Med.
, vol.5
-
-
Kinde, I.1
-
141
-
-
85007618913
-
Genomic analysis of uterine lavage fluid detects early endometrial cancers and reveals a prevalent landscape of driver mutations in women without histopathologic evidence of cancer: A prospective cross-sectional study
-
Nair, N. et al. Genomic analysis of uterine lavage fluid detects early endometrial cancers and reveals a prevalent landscape of driver mutations in women without histopathologic evidence of cancer: a prospective cross-sectional study. PLoS Med. 13, e1002206 (2016).
-
(2016)
PLoS Med.
, vol.13
, pp. e1002206
-
-
Nair, N.1
-
142
-
-
85012982843
-
Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: A cohort study
-
Ross-Innes, C. S. et al. Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study. Lancet Gastroenterol. Hepatol. 2, 23-31 (2016).
-
(2016)
Lancet Gastroenterol. Hepatol.
, vol.2
, pp. 23-31
-
-
Ross-Innes, C.S.1
-
143
-
-
84877578956
-
Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program
-
Chan, K. C. A. et al. Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program. Cancer 119, 1838-1844 (2013).
-
(2013)
Cancer
, vol.119
, pp. 1838-1844
-
-
Chan, K.C.A.1
-
144
-
-
85008415004
-
Molecular triage of premalignant lesions in liquid-based cervical cytology and circulating cell-free DNA from urine, using a panel of methylated human papilloma virus and host genes
-
Guerrero-Preston, R. et al. Molecular triage of premalignant lesions in liquid-based cervical cytology and circulating cell-free DNA from urine, using a panel of methylated human papilloma virus and host genes. Cancer Prev. Res. 9, 915-924 (2016).
-
(2016)
Cancer Prev. Res.
, vol.9
, pp. 915-924
-
-
Guerrero-Preston, R.1
-
145
-
-
84929991442
-
High burden and pervasive positive selection of somatic mutations in normal human skin
-
Martincorena, I. et al. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348, 880-886 (2015).
-
(2015)
Science
, vol.348
, pp. 880-886
-
-
Martincorena, I.1
-
146
-
-
84920024296
-
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
-
Genovese, G. et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N. Engl. J. Med. 371, 2477-2487 (2014).
-
(2014)
N. Engl. J. Med.
, vol.371
, pp. 2477-2487
-
-
Genovese, G.1
-
147
-
-
85027949239
-
Identification of circulating tumor DNA for the early detection of small-cell lung cancer
-
Fernandez-Cuesta, L. et al. Identification of circulating tumor DNA for the early detection of small-cell lung cancer. eBioMedicine 10, 6-12 (2016).
-
(2016)
EBioMedicine
, vol.10
, pp. 6-12
-
-
Fernandez-Cuesta, L.1
-
148
-
-
41849114566
-
MicroRNAs accurately identify cancer tissue origin
-
Rosenfeld, N. et al. MicroRNAs accurately identify cancer tissue origin. Nat. Biotechnol. 26, 462-469 (2008).
-
(2008)
Nat. Biotechnol.
, vol.26
, pp. 462-469
-
-
Rosenfeld, N.1
-
149
-
-
85027947285
-
A minimally-invasive blood-derived biomarker of oligodendrocyte cell-loss in multiple sclerosis
-
Olsen, J. A. et al. A minimally-invasive blood-derived biomarker of oligodendrocyte cell-loss in multiple sclerosis. eBioMedicine 10, 227-235 (2016).
-
(2016)
EBioMedicine
, vol.10
, pp. 227-235
-
-
Olsen, J.A.1
-
150
-
-
84863393080
-
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing
-
Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883-892 (2012).
-
(2012)
N. Engl. J. Med.
, vol.366
, pp. 883-892
-
-
Gerlinger, M.1
-
151
-
-
84936890500
-
Subclonal diversification of primary breast cancer revealed by multiregion sequencing
-
Yates, L. R. et al. Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat. Med. 21, 751-759 (2015).
-
(2015)
Nat. Med.
, vol.21
, pp. 751-759
-
-
Yates, L.R.1
-
152
-
-
84963585216
-
Metastasis as an evolutionary process
-
Turajlic, S. & Swanton, C. Metastasis as an evolutionary process. Science 352, 169-175 (2016).
-
(2016)
Science
, vol.352
, pp. 169-175
-
-
Turajlic, S.1
Swanton, C.2
-
153
-
-
84937414146
-
T790 wild-type clones following treatment of T790M-positive cancers with a third-generation EGFR inhibitor
-
T790 wild-type clones following treatment of T790M-positive cancers with a third-generation EGFR inhibitor. Cancer Discov. 5, 37-54 (2015).
-
(2015)
Cancer Discov.
, vol.5
, pp. 37-54
-
-
Piotrowska, Z.1
-
154
-
-
84893025530
-
Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: The role of massively parallel sequencing
-
De Mattos-Arruda, L. et al. Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: the role of massively parallel sequencing. Mol. Oncol. 8, 150-158 (2014).
-
(2014)
Mol. Oncol.
, vol.8
, pp. 150-158
-
-
De Mattos-Arruda, L.1
-
155
-
-
84888119068
-
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing
-
Chan, K. C. A. et al. Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing. Proc. Natl Acad. Sci. USA 110, 18761-18768 (2013).
-
(2013)
Proc. Natl Acad. Sci. USA
, vol.110
, pp. 18761-18768
-
-
Chan, K.C.A.1
-
156
-
-
84899114624
-
Comparison of KRAS mutation analysis of primary tumors and matched circulating cell-free DNA in plasmas of patients with colorectal cancer
-
Kuo, Y.-B., Chen, J. S., Fand, C. W., Li, Y. S. & Chan, E. C. Comparison of KRAS mutation analysis of primary tumors and matched circulating cell-free DNA in plasmas of patients with colorectal cancer. Clin. Chim. Acta 433, 284-289 (2014).
-
(2014)
Clin. Chim. Acta
, vol.433
, pp. 284-289
-
-
Kuo, Y.-B.1
Chen, J.S.2
Fand, C.W.3
Li, Y.S.4
Chan, E.C.5
-
157
-
-
84907855592
-
Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
-
de Bruin, E. C. et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science 346, 251-256 (2014).
-
(2014)
Science
, vol.346
, pp. 251-256
-
-
De Bruin, E.C.1
-
158
-
-
84907808265
-
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
-
Zhang, J. et al. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science 346, 256-259 (2014).
-
(2014)
Science
, vol.346
, pp. 256-259
-
-
Zhang, J.1
-
159
-
-
84990050278
-
Association between plasma genotyping and outcomes of treatment with osimertinib (AZD9291) in advanced non-small-cell lung cancer
-
Oxnard, G. R. et al. Association between plasma genotyping and outcomes of treatment with osimertinib (AZD9291) in advanced non-small-cell lung cancer. J. Clin. Oncol. 34, 3375-3382 (2016).
-
(2016)
J. Clin. Oncol.
, vol.34
, pp. 3375-3382
-
-
Oxnard, G.R.1
-
160
-
-
84936748494
-
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
-
Siravegna, G. et al. Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. Nat. Med. 21, 795-801 (2015).
-
(2015)
Nat. Med.
, vol.21
, pp. 795-801
-
-
Siravegna, G.1
-
161
-
-
84941630950
-
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
-
Tie, J. et al. Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer. Ann. Oncol. 26, 1715-1722 (2015).
-
(2015)
Ann. Oncol.
, vol.26
, pp. 1715-1722
-
-
Tie, J.1
-
162
-
-
84974625022
-
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
-
Chabon, J. J. et al. Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients. Nat. Commun. 7, 11815 (2016).
-
(2016)
Nat. Commun.
, vol.7
, pp. 11815
-
-
Chabon, J.J.1
-
163
-
-
84965092386
-
Association of EGFR L858R mutation in circulating free DNA with survival in the EURTAC trial
-
Karachaliou, N. et al. Association of EGFR L858R mutation in circulating free DNA with survival in the EURTAC trial. JAMA Oncol. 1, 149-157 (2015).
-
(2015)
JAMA Oncol.
, vol.1
, pp. 149-157
-
-
Karachaliou, N.1
-
164
-
-
84991067898
-
Circulating free tumor-derived DNA (ctDNA) determination of EGFR mutation status in European and Japanese patients with advanced NSCLC: The ASSESS study
-
Reck, M. et al. Circulating free tumor-derived DNA (ctDNA) determination of EGFR mutation status in European and Japanese patients with advanced NSCLC: the ASSESS study. J. Thorac. Oncol. 11, 1682-1689 (2016).
-
(2016)
J. Thorac. Oncol.
, vol.11
, pp. 1682-1689
-
-
Reck, M.1
-
165
-
-
84969315780
-
Determining the prevalence of EGFR mutations in Asian and Russian patients (pts) with advanced non-small-cell lung cancer (aNSCLC) of adenocarcinoma (ADC) and non-ADC histology: IGNITE study
-
Han, B. et al. Determining the prevalence of EGFR mutations in Asian and Russian patients (pts) with advanced non-small-cell lung cancer (aNSCLC) of adenocarcinoma (ADC) and non-ADC histology: IGNITE study. Ann. Oncol. 26, i29-i44 (2015).
-
(2015)
Ann. Oncol.
, vol.26
, pp. i29-i44
-
-
Han, B.1
-
166
-
-
84906250256
-
Gefitinib treatment in EGFR mutated Caucasian NSCLC
-
Douillard, J.-Y. et al. Gefitinib treatment in EGFR mutated Caucasian NSCLC. J. Thorac. Oncol. 9, 1345-1353 (2014).
-
(2014)
J. Thorac. Oncol.
, vol.9
, pp. 1345-1353
-
-
Douillard, J.-Y.1
-
167
-
-
85012921202
-
Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer
-
Normanno, N., Denis, M. G., Thress, K. S., Ratcliffe, M. & Reck, M. Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer. Oncotarget http://dx.doi.org/10.18632/oncotarget.13915 (2016).
-
(2016)
Oncotarget
-
-
Normanno, N.1
Denis, M.G.2
Thress, K.S.3
Ratcliffe, M.4
Reck, M.5
-
168
-
-
84891879491
-
First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: A phase-IV, open-label, single-arm study
-
Douillard, J.-Y. et al. First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study. Br. J. Cancer 110, 55-62 (2014).
-
(2014)
Br. J. Cancer
, vol.110
, pp. 55-62
-
-
Douillard, J.-Y.1
-
169
-
-
85013382512
-
Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer
-
Mok, T. S. et al. Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer. N. Engl. J. Med. http://dx.doi.org/10.1056/NEJMoa1612674 (2016).
-
(2016)
N. Engl. J. Med
-
-
Mok, T.S.1
-
170
-
-
84918789657
-
Monitoring of epidermal growth factor receptor tyrosine kinase inhibitor-sensitizing and resistance mutations in the plasma DNA of patients with advanced non-small cell lung cancer during treatment with erlotinib
-
Sorensen, B. S. et al. Monitoring of epidermal growth factor receptor tyrosine kinase inhibitor-sensitizing and resistance mutations in the plasma DNA of patients with advanced non-small cell lung cancer during treatment with erlotinib. Cancer 120, 3896-3901 (2014).
-
(2014)
Cancer
, vol.120
, pp. 3896-3901
-
-
Sorensen, B.S.1
-
171
-
-
84896539307
-
Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA
-
Oxnard, G. R. et al. Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA. Clin. Cancer Res. 20, 1698-705 (2014).
-
(2014)
Clin. Cancer Res.
, vol.20
, pp. 1698-1705
-
-
Oxnard, G.R.1
-
172
-
-
84949205332
-
EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291
-
Thress, K. S. et al. EGFR mutation detection in ctDNA from NSCLC patient plasma: a cross-platform comparison of leading technologies to support the clinical development of AZD9291. Lung Cancer 90, 509-515 (2015).
-
(2015)
Lung Cancer
, vol.90
, pp. 509-515
-
-
Thress, K.S.1
-
173
-
-
85016323687
-
Osimertinib benefit in EGFR-mutant NSCLC patients with T790M-mutation detected by circulating tumour DNA
-
Remon, J. et al. Osimertinib benefit in EGFR-mutant NSCLC patients with T790M-mutation detected by circulating tumour DNA. Annc. Oncol. doi.dx.org:/10.1093/annonc/mdx017 (2017).
-
(2017)
Annc. Oncol
-
-
Remon, J.1
-
174
-
-
85016257233
-
-
European Medicines Agency EMA
-
European Medicines Agency. Iressa: public assessment report-product information. EMA http://www.ema.europa.eu/docs/en GB/document library/EPAR-Product Information/human/001016/WC500036358.pdf (2016).
-
(2016)
Iressa: Public Assessment Report-product Information
-
-
-
175
-
-
85016257233
-
-
European Medicines Agency EMA
-
European Medicines Agency. Tagrisso: public assessment report-product information. EMA http://www.ema.europa.eu/docs/en GB/document library/EPAR-Product Information/human/004124/WC500202022.pdf (2016).
-
(2016)
Tagrisso: Public Assessment Report-product Information
-
-
-
176
-
-
85016265873
-
-
US National Library of Medicine. ClinicalTrials.gov
-
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02693535 (2017).
-
(2017)
-
-
-
177
-
-
84995670109
-
Use of liquid biopsies in clinical oncology: Pilot experience in 168 patients
-
Schwaederle, M. et al. Use of liquid biopsies in clinical oncology: pilot experience in 168 patients. Clin. Cancer Res. 22, 5497-5505 (2016).
-
(2016)
Clin. Cancer Res.
, vol.22
, pp. 5497-5505
-
-
Schwaederle, M.1
-
178
-
-
85016231411
-
-
US National Library of Medicine. ClinicalTrials.gov
-
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02140463 (2015).
-
(2015)
-
-
-
180
-
-
85016245570
-
-
Institut Gustave Roussy. The prospective MOSCATO 01 trial demonstrates that molecular "portraits" improve outcome of patients with metastatic cancer. PRNewswire
-
Institut Gustave Roussy. The prospective MOSCATO 01 trial demonstrates that molecular "portraits" improve outcome of patients with metastatic cancer. PRNewswire http://www.prnewswire.com/news-releases/the-prospective-moscato-01-trial-demonstrates-that-molecular-portraits-improve-outcome-of-patients-with-metastatic-cancer-594507371.html (2016).
-
(2016)
-
-
-
181
-
-
85031021044
-
A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative
-
Pishvaian, M. J. et al. A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative. Oncotarget http://dx.doi.org/10.18632/oncotarget.13225 (2016).
-
(2016)
Oncotarget
-
-
Pishvaian, M.J.1
-
182
-
-
84877806778
-
Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer
-
Heitzer, E. et al. Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer. Int. J. Cancer 133, 346-356 (2013).
-
(2013)
Int. J. Cancer
, vol.133
, pp. 346-356
-
-
Heitzer, E.1
-
183
-
-
84897389811
-
Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing
-
Mohan, S. et al. Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing. PLoS Genet. 10, e1004271 (2014).
-
(2014)
PLoS Genet.
, vol.10
, pp. e1004271
-
-
Mohan, S.1
-
184
-
-
84864014971
-
FAST-SeqS: A simple and efficient method for the detection of aneuploidy by massively parallel sequencing
-
Kinde, I., Papadopoulos, N., Kinzler, K. W. & Vogelstein, B. FAST-SeqS: a simple and efficient method for the detection of aneuploidy by massively parallel sequencing. PLoS ONE 7, e41162 (2012).
-
(2012)
PLoS ONE
, vol.7
, pp. e41162
-
-
Kinde, I.1
Papadopoulos, N.2
Kinzler, K.W.3
Vogelstein, B.4
-
185
-
-
85016288095
-
Detection, frequency and actionability of recurrent copy number gains detected by non-invasive liquid biopsy of 3, 942 lung and breast cancer samples
-
Abdueva, D. et al. Detection, frequency and actionability of recurrent copy number gains detected by non-invasive liquid biopsy of 3, 942 lung and breast cancer samples. J. Clin. Oncol. 34, abstr. 11541 (2016).
-
(2016)
J. Clin. Oncol.
, vol.34
, pp. 11541
-
-
Abdueva, D.1
-
186
-
-
84925338452
-
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
-
Jiang, P. et al. Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients. Proc. Natl Acad. Sci. USA 112, E1317-E1325 (2015).
-
(2015)
Proc. Natl Acad. Sci. USA
, vol.112
, pp. E1317-E1325
-
-
Jiang, P.1
-
187
-
-
84947245381
-
Plasma AR and abiraterone-resistant prostate cancer
-
Romanel, A. et al. Plasma AR and abiraterone-resistant prostate cancer. Sci. Transl Med. 7, 312re10 (2015).
-
(2015)
Sci. Transl Med.
, vol.7
, pp. 312re10
-
-
Romanel, A.1
-
188
-
-
84964224932
-
Bias-corrected targeted next-generation sequencing for rapid, multiplexed detection of actionable alterations in cell-free DNA from advanced lung cancer patients
-
Paweletz, C. P. et al. Bias-corrected targeted next-generation sequencing for rapid, multiplexed detection of actionable alterations in cell-free DNA from advanced lung cancer patients. Clin. Cancer Res. 22, 915-922 (2016).
-
(2016)
Clin. Cancer Res.
, vol.22
, pp. 915-922
-
-
Paweletz, C.P.1
-
189
-
-
85007593294
-
Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors
-
Schreuer, M. et al. Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors. J. Transl Med. 14, 95 (2016).
-
(2016)
J. Transl Med.
, vol.14
, pp. 95
-
-
Schreuer, M.1
-
190
-
-
84942521073
-
Early prediction of response to tyrosine kinase inhibitors by quantification of EGFR mutations in plasma of NSCLC patients
-
Marchetti, A. et al. Early prediction of response to tyrosine kinase inhibitors by quantification of EGFR mutations in plasma of NSCLC patients. J. Thorac. Oncol. 10, 1437-1443 (2015).
-
(2015)
J. Thorac. Oncol.
, vol.10
, pp. 1437-1443
-
-
Marchetti, A.1
-
191
-
-
84995917584
-
Circulating tumor DNA as an early indicator of response to T-cell transfer immunotherapy in metastatic melanoma
-
Xi, L. et al. Circulating tumor DNA as an early indicator of response to T-cell transfer immunotherapy in metastatic melanoma. Clin. Cancer Res. 22, 5480-5486 (2016).
-
(2016)
Clin. Cancer Res.
, vol.22
, pp. 5480-5486
-
-
Xi, L.1
-
193
-
-
84978062740
-
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
-
Tie, J. et al. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. Sci. Transl Med. 8, 346ra92 (2016).
-
(2016)
Sci. Transl Med.
, vol.8
, pp. 346ra92
-
-
Tie, J.1
-
194
-
-
84940416459
-
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
-
Garcia-Murillas, I. et al. Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer. Sci. Transl Med. 7, 302ra133 (2015).
-
(2015)
Sci. Transl Med.
, vol.7
, pp. 302ra133
-
-
Garcia-Murillas, I.1
-
195
-
-
84930038230
-
Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery
-
Reinert, T. et al. Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery. Gut 65, 625-634 (2015).
-
(2015)
Gut
, vol.65
, pp. 625-634
-
-
Reinert, T.1
-
196
-
-
84938414305
-
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
-
Olsson, E. et al. Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease. EMBO Mol. Med. 7, 1034-1047 (2015).
-
(2015)
EMBO Mol. Med.
, vol.7
, pp. 1034-1047
-
-
Olsson, E.1
-
197
-
-
77952962769
-
Development of personalized tumor biomarkers using massively parallel sequencing
-
Leary, R. J. et al. Development of personalized tumor biomarkers using massively parallel sequencing. Sci. Transl Med. 2, 20ra14 (2010).
-
(2010)
Sci. Transl Med.
, vol.2
, pp. 20ra14
-
-
Leary, R.J.1
-
198
-
-
77957911880
-
Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors
-
Mcbride, D. J. et al. Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors. Genes Chromosomes Cancer 49, 1062-1069 (2011).
-
(2011)
Genes Chromosomes Cancer
, vol.49
, pp. 1062-1069
-
-
McBride, D.J.1
-
199
-
-
84954060726
-
Acquired resistance to the TRK inhibitor entrectinib in colorectal cancer
-
Russo, M. et al. Acquired resistance to the TRK inhibitor entrectinib in colorectal cancer. Cancer Discov. 6, 36-44 (2016).
-
(2016)
Cancer Discov.
, vol.6
, pp. 36-44
-
-
Russo, M.1
-
200
-
-
84862999938
-
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
-
Misale, S. et al. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer. Nature 486, 532-536 (2012).
-
(2012)
Nature
, vol.486
, pp. 532-536
-
-
Misale, S.1
-
201
-
-
84863000299
-
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
-
Diaz, L. A. J. et al. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 486, 537-540 (2012).
-
(2012)
Nature
, vol.486
, pp. 537-540
-
-
Diaz, L.A.J.1
-
202
-
-
84984621921
-
Pros: Can tissue biopsy be replaced by liquid biopsy?
-
Ilié, M. & Hofman, P. Pros: can tissue biopsy be replaced by liquid biopsy? Transl Lung Cancer Res. 5, 420-423 (2016).
-
(2016)
Transl Lung Cancer Res.
, vol.5
, pp. 420-423
-
-
Ilié, M.1
Hofman, P.2
-
203
-
-
84930755018
-
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M
-
Thress, K. S. et al. Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M. Nat. Med. 21, 560-562 (2015).
-
(2015)
Nat. Med.
, vol.21
, pp. 560-562
-
-
Thress, K.S.1
-
204
-
-
84957063275
-
Tumor heterogeneity and lesion-specific response to targeted therapy in colorectal cancer
-
Russo, M. et al. Tumor heterogeneity and lesion-specific response to targeted therapy in colorectal cancer. Cancer Discov. 6, 147-153 (2015).
-
(2015)
Cancer Discov.
, vol.6
, pp. 147-153
-
-
Russo, M.1
-
205
-
-
84926431987
-
Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment
-
Morelli, M. P. et al. Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment. Ann. Oncol. 26, 731-736 (2015).
-
(2015)
Ann. Oncol.
, vol.26
, pp. 731-736
-
-
Morelli, M.P.1
-
206
-
-
85016264335
-
Distinct sub-clonal tumour responses to therapy revealed by circulating cell-free DNA
-
Gremel, G. et al. Distinct sub-clonal tumour responses to therapy revealed by circulating cell-free DNA. Ann. Oncol. 27, 1959-1965 (2016).
-
(2016)
Ann. Oncol.
, vol.27
, pp. 1959-1965
-
-
Gremel, G.1
-
207
-
-
84975744385
-
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer
-
Ulz, P. et al. Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer. Nat. Commun. 7, 12008 (2016).
-
(2016)
Nat. Commun.
, vol.7
, pp. 12008
-
-
Ulz, P.1
-
209
-
-
85016321022
-
-
US National Library of Medicine. ClinicalTrials.gov
-
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02284633 (2015).
-
(2015)
-
-
-
210
-
-
85016330121
-
-
US National Library of Medicine. ClinicalTrials.gov
-
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02743910 (2016).
-
(2016)
-
-
-
211
-
-
85016245774
-
-
International Standard Randomised Controlled Trials Number Registry. isrctn.com
-
International Standard Randomised Controlled Trials Number Registry. isrctn.com http://www.isrctn.com/ISRCTN16945804 (2016).
-
(2016)
-
-
-
212
-
-
84905190838
-
Cellular barcoding: A technical appraisal
-
Naik, S. H., Schumacher, T. N. & Perie, L. Cellular barcoding: a technical appraisal. Exp. Hematol. 42, 598-608 (2014).
-
(2014)
Exp. Hematol.
, vol.42
, pp. 598-608
-
-
Naik, S.H.1
Schumacher, T.N.2
Perie, L.3
-
213
-
-
84975076514
-
Circulating DNA as a strong multimarker prognostic tool for metastatic colorectal cancer patient management care
-
El Messaoudi, S. et al. Circulating DNA as a strong multimarker prognostic tool for metastatic colorectal cancer patient management care. Clin. Cancer Res. 22, 3067-3077 (2016).
-
(2016)
Clin. Cancer Res.
, vol.22
, pp. 3067-3077
-
-
El Messaoudi, S.1
-
214
-
-
84906245875
-
Changes in mutational status during third-line treatment for metastatic colorectal cancer-results of consecutive measurement of cell free DNA KRAS and BRAF in the plasma
-
Spindler, K. L. G., Pallisgaard, N., Andersen, R. F. & Jakobsen, A. Changes in mutational status during third-line treatment for metastatic colorectal cancer-results of consecutive measurement of cell free DNA, KRAS and BRAF in the plasma. Int. J. Cancer 135, 2215-2222 (2014).
-
(2014)
Int. J. Cancer
, vol.135
, pp. 2215-2222
-
-
Spindler, K.L.G.1
Pallisgaard, N.2
Andersen, R.F.3
Jakobsen, A.4
-
215
-
-
79957458567
-
Cell-free nucleic acids as biomarkers in cancer patients
-
Schwarzenbach, H., Hoon, D. S. B. & Pantel, K. Cell-free nucleic acids as biomarkers in cancer patients. Nat. Rev. Cancer 11, 426-437 (2011).
-
(2011)
Nat. Rev. Cancer
, vol.11
, pp. 426-437
-
-
Schwarzenbach, H.1
Hoon, D.S.B.2
Pantel, K.3
-
216
-
-
85016247825
-
Plasma-based monitoring of BRAF mutations during therapy for malignant melanoma using combined exosomal RNA and cell-free DNA analysis
-
Sullivan, R. J. et al. Plasma-based monitoring of BRAF mutations during therapy for malignant melanoma using combined exosomal RNA and cell-free DNA analysis. J. Clin. Oncol. 33, 9017 (2015).
-
(2015)
J. Clin. Oncol.
, vol.33
, pp. 9017
-
-
Sullivan, R.J.1
-
217
-
-
84984616776
-
Inferring expressed genes by whole-genome sequencing of plasma DNA
-
Ulz, P. et al. Inferring expressed genes by whole-genome sequencing of plasma DNA. Nat. Genet. 48, 1273-1278 (2016).
-
(2016)
Nat. Genet.
, vol.48
, pp. 1273-1278
-
-
Ulz, P.1
-
218
-
-
84929224664
-
Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma
-
Shao, H. et al. Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma. Nat. Commun. 6, 6999 (2015).
-
(2015)
Nat. Commun.
, vol.6
, pp. 6999
-
-
Shao, H.1
-
219
-
-
84964700391
-
Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy
-
Alix-Panabières, C. & Pantel, K. Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy. Cancer Discov. 6, 479-491 (2016).
-
(2016)
Cancer Discov.
, vol.6
, pp. 479-491
-
-
Alix-Panabières, C.1
Pantel, K.2
-
220
-
-
84946568126
-
RNA-seq of tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular pathway cancer diagnostics
-
Best, M. G. et al. RNA-seq of tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular pathway cancer diagnostics. Cancer Cell 28, 666-676 (2015).
-
(2015)
Cancer Cell
, vol.28
, pp. 666-676
-
-
Best, M.G.1
-
221
-
-
34248569300
-
Circulating free DNA in plasma or serum as biomarker of carcinogenesis: Practical aspects and biological significance
-
Gormally, E., Caboux, E., Vineis, P. & Hainaut, P. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat. Res. 635, 105-117 (2007).
-
(2007)
Mutat. Res.
, vol.635
, pp. 105-117
-
-
Gormally, E.1
Caboux, E.2
Vineis, P.3
Hainaut, P.4
-
222
-
-
84994885645
-
The cancer bloodhounds
-
Webb, S. The cancer bloodhounds. Nat. Biotechnol. 34, 1090-1094 (2016).
-
(2016)
Nat. Biotechnol.
, vol.34
, pp. 1090-1094
-
-
Webb, S.1
-
223
-
-
84958104979
-
Sense and nonsense in the process of accreditation of a pathology laboratory
-
Long-Mira, E., Washetine, K. & Hofman, P. Sense and nonsense in the process of accreditation of a pathology laboratory. Virchows Arch. 468, 43-49 (2016).
-
(2016)
Virchows Arch.
, vol.468
, pp. 43-49
-
-
Long-Mira, E.1
Washetine, K.2
Hofman, P.3
-
224
-
-
84942940354
-
Multi-center evaluation of the novel fully-automated PCR-based Idylla BRAF mutation test on formalin-fixed paraffin-embedded tissue of malignant melanoma
-
Melchior, L. et al. Multi-center evaluation of the novel fully-automated PCR-based Idylla BRAF mutation test on formalin-fixed paraffin-embedded tissue of malignant melanoma. Exp. Mol. Pathol. 99, 485-491 (2015).
-
(2015)
Exp. Mol. Pathol.
, vol.99
, pp. 485-491
-
-
Melchior, L.1
-
225
-
-
84971516426
-
BRAF mutation testing in cell-free DNA from the plasma of patients with advanced cancers using a rapid, automated molecular diagnostics system
-
Janku, F. et al. BRAF mutation testing in cell-free DNA from the plasma of patients with advanced cancers using a rapid, automated molecular diagnostics system. Mol. Cancer Ther. 15, 1397-1404 (2016).
-
(2016)
Mol. Cancer Ther.
, vol.15
, pp. 1397-1404
-
-
Janku, F.1
-
226
-
-
84959039248
-
Nanopore sequencing detects structural variants in cancer
-
Norris, A. L., Workman, R. E., Fan, Y., Eshleman, J. R. & Timp, W. Nanopore sequencing detects structural variants in cancer. Cancer Biol. Ther. 17, 246-253 (2016).
-
(2016)
Cancer Biol. Ther.
, vol.17
, pp. 246-253
-
-
Norris, A.L.1
Workman, R.E.2
Fan, Y.3
Eshleman, J.R.4
Timp, W.5
-
227
-
-
84958068536
-
Real-time, portable genome sequencing for Ebola surveillance
-
Quick, J. et al. Real-time, portable genome sequencing for Ebola surveillance. Nature 530, 228-232 (2016).
-
(2016)
Nature
, vol.530
, pp. 228-232
-
-
Quick, J.1
-
228
-
-
84953865446
-
Rapid short-read sequencing and aneuploidy detection using minION nanopore technology
-
Wei, S. & Williams, Z. Rapid short-read sequencing and aneuploidy detection using minION nanopore technology. Genetics 202, 37-44 (2016).
-
(2016)
Genetics
, vol.202
, pp. 37-44
-
-
Wei, S.1
Williams, Z.2
-
229
-
-
84970952281
-
MinION Analysis and Reference Consortium: Phase 1 data release and analysis
-
Ip, C. L. C. et al. MinION Analysis and Reference Consortium: phase 1 data release and analysis. F1000Res. 4, 1075 (2015).
-
(2015)
F1000Res.
, vol.4
, pp. 1075
-
-
Ip, C.L.C.1
-
230
-
-
84980361397
-
Real-time selective sequencing using nanopore technology
-
Loose, M., Malla, S. & Stout, M. Real-time selective sequencing using nanopore technology. Nat. Methods 13, 751-754 (2016).
-
(2016)
Nat. Methods
, vol.13
, pp. 751-754
-
-
Loose, M.1
Malla, S.2
Stout, M.3
-
231
-
-
33749573192
-
Higher amount of free circulating DNA in serum than in plasma is not mainly caused by contaminated extraneous DNA during separation
-
Umetani, N., Hiramatsu, S. & Hoon, D. S. B. Higher amount of free circulating DNA in serum than in plasma is not mainly caused by contaminated extraneous DNA during separation. Ann. NY Acad. Sci. 1075, 299-307 (2006).
-
(2006)
Ann. NY Acad. Sci.
, vol.1075
, pp. 299-307
-
-
Umetani, N.1
Hiramatsu, S.2
Hoon, D.S.B.3
-
232
-
-
0027401597
-
Plasma collected from heparinized blood is not suitable for HCV-RNA detection by conventional RT-PCR assay
-
Willems, M., Moshage, H., Nevens, F., Fevery, J. & Yap, S. H. Plasma collected from heparinized blood is not suitable for HCV-RNA detection by conventional RT-PCR assay. J. Virol. Methods 42, 127-130 (1993).
-
(1993)
J. Virol. Methods
, vol.42
, pp. 127-130
-
-
Willems, M.1
Moshage, H.2
Nevens, F.3
Fevery, J.4
Yap, S.H.5
-
233
-
-
0038697547
-
Changes in concentration of DNA in serum and plasma during storage of blood samples
-
Jung, M., Klotzek, S., Lewandowski, M., Fleischhacker, M. & Jung, K. Changes in concentration of DNA in serum and plasma during storage of blood samples. Clin. Chem. 49, 1028-1029 (2003).
-
(2003)
Clin. Chem.
, vol.49
, pp. 1028-1029
-
-
Jung, M.1
Klotzek, S.2
Lewandowski, M.3
Fleischhacker, M.4
Jung, K.5
-
234
-
-
85020448949
-
The effect of preservative and temperature on the analysis of circulating tumor DNA
-
Parpart-Li, S. et al. The effect of preservative and temperature on the analysis of circulating tumor DNA. Clin. Cancer Res. http://dx.doi.org/10.1158/1078-0432.CCR-16-1691 (2016).
-
(2016)
Clin. Cancer Res
-
-
Parpart-Li, S.1
-
235
-
-
84880375472
-
Circulating cell free DNA: Preanalytical considerations
-
El Messaoudi, S., Rolet, F., Mouliere, F. & Thierry, A. R. Circulating cell free DNA: preanalytical considerations. Clin. Chim. Acta 424, 222-230 (2013).
-
(2013)
Clin. Chim. Acta
, vol.424
, pp. 222-230
-
-
El Messaoudi, S.1
Rolet, F.2
Mouliere, F.3
Thierry, A.R.4
-
236
-
-
84960408340
-
Optimised pre-analytical methods improve KRAS mutation detection in circulating tumour DNA (ctDNA) from patients with non-small cell lung cancer (NSCLC)
-
Sherwood, J. L. et al. Optimised pre-analytical methods improve KRAS mutation detection in circulating tumour DNA (ctDNA) from patients with non-small cell lung cancer (NSCLC). PLoS ONE 11, 1-14 (2016).
-
(2016)
PLoS ONE
, vol.11
, pp. 1-14
-
-
Sherwood, J.L.1
-
237
-
-
84943588034
-
Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNA
-
Toro, P. V. et al. Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNA. Clin. Biochem. 48, 993-998 (2015).
-
(2015)
Clin. Biochem.
, vol.48
, pp. 993-998
-
-
Toro, P.V.1
-
238
-
-
84967239521
-
3EDTA, Streck and CellSave blood collection tubes
-
3EDTA, Streck and CellSave blood collection tubes. Clin. Biochem. 49, 1354-1360 (2016).
-
(2016)
Clin. Biochem.
, vol.49
, pp. 1354-1360
-
-
Kang, Q.1
-
239
-
-
84994707439
-
Performance of Streck cfDNA blood collection tubes for liquid biopsy testing
-
Medina Diaz, I. et al. Performance of Streck cfDNA blood collection tubes for liquid biopsy testing. PLoS ONE 11, e0166354 (2016).
-
(2016)
PLoS ONE
, vol.11
, pp. e0166354
-
-
Medina Diaz, I.1
-
240
-
-
84884350975
-
A stabilizing reagent prevents cell-free DNA contamination by cellular DNA in plasma during blood sample storage and shipping as determined by digital PCR
-
Norton, S. E., Lechner, J. M., Williams, T. & Fernando, M. R. A stabilizing reagent prevents cell-free DNA contamination by cellular DNA in plasma during blood sample storage and shipping as determined by digital PCR. Clin. Biochem. 46, 1561-1565 (2013).
-
(2013)
Clin. Biochem.
, vol.46
, pp. 1561-1565
-
-
Norton, S.E.1
Lechner, J.M.2
Williams, T.3
Fernando, M.R.4
-
241
-
-
84984780854
-
Low input whole-exome sequencing to determine the representation of the tumor exome in circulating DNA of non-small cell lung cancer patients
-
Dietz, S. et al. Low input whole-exome sequencing to determine the representation of the tumor exome in circulating DNA of non-small cell lung cancer patients. PLoS ONE 11, e0161012 (2016).
-
(2016)
PLoS ONE
, vol.11
, pp. e0161012
-
-
Dietz, S.1
-
242
-
-
84865979581
-
Detection of ultra-rare mutations by next-generation sequencing
-
Schmitt, M. W. et al. Detection of ultra-rare mutations by next-generation sequencing. Proc. Natl Acad. Sci. USA 109, 14508-14513 (2012).
-
(2012)
Proc. Natl Acad. Sci. USA
, vol.109
, pp. 14508-14513
-
-
Schmitt, M.W.1
-
243
-
-
84978657930
-
Multiplex detection of rare mutations by picoliter droplet based digital PCR: Sensitivity and specificity considerations
-
Zonta, E., Garlan, F., Perez-Toralla, K. & Taly, V. Multiplex detection of rare mutations by picoliter droplet based digital PCR: sensitivity and specificity considerations. PLoS ONE 11, e0159094 (2016).
-
(2016)
PLoS ONE
, vol.11
, pp. e0159094
-
-
Zonta, E.1
Garlan, F.2
Perez-Toralla, K.3
Taly, V.4
-
244
-
-
84923066128
-
Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform
-
Kidess, E. et al. Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform. Oncotarget 6, 2549-2561 (2015).
-
(2015)
Oncotarget
, vol.6
, pp. 2549-2561
-
-
Kidess, E.1
|